WO2005067405A3 - Methode de criblage de reponse a des medicaments efficaces pour traiter ou prevenir le vitiligo et methode permettant de pronostiquer le vitiligo - Google Patents

Methode de criblage de reponse a des medicaments efficaces pour traiter ou prevenir le vitiligo et methode permettant de pronostiquer le vitiligo Download PDF

Info

Publication number
WO2005067405A3
WO2005067405A3 PCT/KR2005/000186 KR2005000186W WO2005067405A3 WO 2005067405 A3 WO2005067405 A3 WO 2005067405A3 KR 2005000186 W KR2005000186 W KR 2005000186W WO 2005067405 A3 WO2005067405 A3 WO 2005067405A3
Authority
WO
WIPO (PCT)
Prior art keywords
vitiligo
prevention
treatment
screening
prognosis
Prior art date
Application number
PCT/KR2005/000186
Other languages
English (en)
Other versions
WO2005067405A2 (fr
Inventor
Ai Young Lee
Nan Hyung Kim
Original Assignee
School Foundation Eulji
Ai Young Lee
Nan Hyung Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by School Foundation Eulji, Ai Young Lee, Nan Hyung Kim filed Critical School Foundation Eulji
Publication of WO2005067405A2 publication Critical patent/WO2005067405A2/fr
Publication of WO2005067405A3 publication Critical patent/WO2005067405A3/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23N—MACHINES OR APPARATUS FOR TREATING HARVESTED FRUIT, VEGETABLES OR FLOWER BULBS IN BULK, NOT OTHERWISE PROVIDED FOR; PEELING VEGETABLES OR FRUIT IN BULK; APPARATUS FOR PREPARING ANIMAL FEEDING- STUFFS
    • A23N17/00—Apparatus specially adapted for preparing animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/32—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from hydrolysates of wood or straw
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/207—Pigmentation disorders

Abstract

L'invention concerne des méthodes et des kits permettant de cribler une réponse à des médicaments efficaces pour traiter ou prévenir le vitiligo, des méthodes et des kits permettant de cribler des ingrédients actifs efficaces pour traiter ou prévenir le vitiligo et des méthodes et des kits permettant de pronostiquer le vitiligo à l'aide du gène 4A1 du facteur d'initiation de traduction eukaryote (eIF4A1), du gène L13 de protéine ribosomale et d'un médiateur de l'ARN polymérase en gène de transcription.
PCT/KR2005/000186 2004-01-20 2005-01-20 Methode de criblage de reponse a des medicaments efficaces pour traiter ou prevenir le vitiligo et methode permettant de pronostiquer le vitiligo WO2005067405A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20040004256 2004-01-20
KR10-2004-0004256 2004-01-20

Publications (2)

Publication Number Publication Date
WO2005067405A2 WO2005067405A2 (fr) 2005-07-28
WO2005067405A3 true WO2005067405A3 (fr) 2005-09-15

Family

ID=34793288

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2005/000186 WO2005067405A2 (fr) 2004-01-20 2005-01-20 Methode de criblage de reponse a des medicaments efficaces pour traiter ou prevenir le vitiligo et methode permettant de pronostiquer le vitiligo

Country Status (2)

Country Link
KR (1) KR100672853B1 (fr)
WO (1) WO2005067405A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100788241B1 (ko) * 2007-01-22 2007-12-27 동국대학교 산학협력단 백반증의 예방 또는 치료물질을 스크리닝하는 방법
KR100951446B1 (ko) * 2009-01-23 2010-04-07 동국대학교 산학협력단 백반증 진단용 ｔｓｌｐ 다형성 마커
KR101146597B1 (ko) * 2010-03-16 2012-05-16 동국대학교 산학협력단 백반증 진단용 조성물
CN114591991B (zh) * 2022-03-31 2023-05-09 西南交通大学 一种基于短链羰基还原酶制备钙泊三醇关键手性中间体的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323219B1 (en) * 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US20030059862A1 (en) * 2001-05-24 2003-03-27 Ruben Steven M. Antibodies against tumor necrosis factor delta (APRIL)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
US6324479B1 (en) * 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US6218122B1 (en) 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323219B1 (en) * 1998-04-02 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Methods for treating immunomediated inflammatory disorders
US20030059862A1 (en) * 2001-05-24 2003-03-27 Ruben Steven M. Antibodies against tumor necrosis factor delta (APRIL)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LE POLE I.C. ET AL: "Altered Gene Expression in Melanocytes Exposed to 4 Tertiary Butyl Phenol (4-TBP): Upregulation of the A2b Adenosine Receptor.", J.INVEST DERMATOL., vol. 113, no. 5, November 1999 (1999-11-01), pages 725 - 731 *
LEE A.Y. ET AL: "All Trans-Retinoic Acid (ATRA) Elevated Eukaryotic Translation Initiation Factor 4A1 (eIF4A1) mRNA in ATRA-Responsive Vitiliginous Epidermis.", PIGMENT CELL RES., vol. 17, no. 6, December 2004 (2004-12-01), pages 659 - 667 *

Also Published As

Publication number Publication date
WO2005067405A2 (fr) 2005-07-28
KR100672853B1 (ko) 2007-01-22
KR20050076690A (ko) 2005-07-26

Similar Documents

Publication Publication Date Title
WO2006031901A3 (fr) Petits arn interferents inhibant efficacement l'expression genique virale et methodes d'utilisation associees
WO2006020768A3 (fr) Oligonucleotides chimiquement modifies
WO2005079363A3 (fr) Agents therapeutiques a base d'aptameres utiles dans le traitement de troubles lies a un complement
WO2003102214A3 (fr) Procede d'interference efficace par arn dans des cellules de mammifere
WO2002052031A3 (fr) Amplification d'acide nucleique
WO2006060680A3 (fr) Variants de la proteine mda-7 presentant une activite antiproliferative
WO2007103018A3 (fr) Recuperation de l'acide nucleique present dans les tissus degrades ou fixes au formol et enrobes de paraffine et utilisations dudit acide
WO2006085906A3 (fr) Methode de detection directe d'arn de diagnostic
WO2006036922A3 (fr) Corps mimetiques srage, compositions, et methodes d'utilisation
WO2005105157A3 (fr) Inhibition d'un arnm associe a une proteine du gene hairless (sans poil)
EP2046990A4 (fr) Procédé de dénaturation et de fragmentation d'adn ou d'arn par ultrasons
WO2007092645A3 (fr) Nouvelles combinaisons d'inhibiteurs du vhc et méthodes
WO2004027024A3 (fr) Isolement de molecules geniques a partir d'une construction biologique complexe, a utiliser dans une analyse d'expression genique
WO2005074655A3 (fr) Materiaux et procede favorisant la regeneration nerveuse
EP1884771A4 (fr) Membrane a proteine immobilisee, procede pour l'immobilisation de proteine, electrode a enzyme immobilisee, et capteur biologique
WO2006045591A3 (fr) Procede et produits de synthese permettant d'administrer un arn en double brin a des organismes de parasites
WO2007032794A3 (fr) Inhibition de l'expression genique virale a l'aide d'un petit arn interferent
WO2005073380A3 (fr) Systemes d'expression regulee de la polymerase iii et methodes associees
WO2005067405A3 (fr) Methode de criblage de reponse a des medicaments efficaces pour traiter ou prevenir le vitiligo et methode permettant de pronostiquer le vitiligo
WO2004071430A3 (fr) Ciblage iarn de virus
WO2007101063A3 (fr) Traitement de troubles liés au développement
AU2003265884A1 (en) Target and method for inhibition of bacterial rna polymerase
WO2005001039A3 (fr) Production de petits arn interferents (arnsi) regulee par les ribozymes et procedes d'utilisation de ceux-ci
WO2007076143A3 (fr) Ensembles d'amorces specifiques d'especes et identification de sequences d'adn specifiques d'especes au moyen de l'enrichissement de fragments genomiques
WO2004053078A3 (fr) Methodes de modulation de l'activite ikk?

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase